<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H3631955F86264C5A8050C92AA660C32D" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 8968 IH: Protecting Kids from Fentanyl Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-09-22</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 8968</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220922">September 22, 2022</action-date><action-desc><sponsor name-id="L000564">Mr. Lamborn</sponsor> (for himself, <cosponsor name-id="B001299">Mr. Banks</cosponsor>, <cosponsor name-id="G000576">Mr. Grothman</cosponsor>, <cosponsor name-id="H001053">Mrs. Hartzler</cosponsor>, <cosponsor name-id="J000304">Mr. Jackson</cosponsor>, <cosponsor name-id="B001291">Mr. Babin</cosponsor>, <cosponsor name-id="D000032">Mr. Donalds</cosponsor>, <cosponsor name-id="M001212">Mr. Moore of Alabama</cosponsor>, <cosponsor name-id="I000056">Mr. Issa</cosponsor>, <cosponsor name-id="P000048">Mr. Pfluger</cosponsor>, <cosponsor name-id="N000190">Mr. Norman</cosponsor>, <cosponsor name-id="N000191">Mr. Neguse</cosponsor>, and <cosponsor name-id="B001257">Mr. Bilirakis</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HED00">Committee on Education and Labor</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To allow States and local educational agencies to use unspent COVID–19 elementary and secondary school emergency relief funds to purchase life-saving opioid antagonists and to provide related training and education to students and teachers.</official-title></form><legis-body id="H7558D80B695947F5A9E66A9670F15B76" style="OLC"><section id="H01A606D8997748D8A1AF0C0028AAB342" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Protecting Kids from Fentanyl Act</short-title></quote>.</text></section><section id="H0A19B81FDF8C45F69399C8C4F2677C5D"><enum>2.</enum><header>Additional funds for opioid antagonists and related training and education</header><subsection id="HC70DE8A730794B629C9A69D1E81B6A83"><enum>(a)</enum><header>In general</header><text>Notwithstanding any other provision of law, a State or local educational agency that has received funds under an ESSERF program may, in lieu of the original requested or authorized use for such funds, use a portion, or all, of the unexpended funds to carry out one or more of the following activities:</text><paragraph id="H2AA5053BA1EA4EDF8F7FB4D068615BA1"><enum>(1)</enum><text display-inline="yes-display-inline">Purchase naloxone or other opioid antagonists.</text></paragraph><paragraph id="HB5A3890C47474E01A6AE8100BEF3F1B0"><enum>(2)</enum><text>Provide training to school nurses, teachers, school administrators, and school resource officers on how to administer naloxone or other opioid antagonists.</text></paragraph><paragraph id="H4ABE0B5D572E4ED2ABA245D8C22A12B7"><enum>(3)</enum><text>Provide fentanyl awareness classes or materials to students.</text></paragraph></subsection><subsection id="HAF3ACEF9085845DC87BCC94185EE77C0"><enum>(b)</enum><header>Limitations on Secretarial authority</header><text>The Secretary of Education shall not—</text><paragraph id="HE1DC4D7C65944D64BFF5DE3A8C6CAB15"><enum>(1)</enum><text display-inline="yes-display-inline">require the use of funds under subsection (a) to be in response to, or in any way connected with, COVID–19; or</text></paragraph><paragraph id="HF850A4C4A0F54D189417E7372C8E95DC"><enum>(2)</enum><text display-inline="yes-display-inline">prevent or discourage a State or local educational agency from using ESSERF program funds to carry out any of the activities authorized under subsection (a).</text></paragraph></subsection><subsection id="HE0A6944BCE0740999BD80A75DDCAEABA"><enum>(c)</enum><header>Rule of construction</header><text display-inline="yes-display-inline">Nothing in this Act shall be construed to supercede any State law regulating the use of naloxone or other opioid antagonists in schools.</text></subsection><subsection id="H530AB770302B4AD0B3A05CC41CF3FB19"><enum>(d)</enum><header>Definitions</header><text>In this section:</text><paragraph id="HCF6EF327EC7F4EBF8BE3A4A0652EE0FE"><enum>(1)</enum><header>ESSERF program</header><text>The term <term>ESSERF program</term> means a program carried out under—</text><subparagraph id="HD552B26D536344059E3F3BFD0BE60C4D"><enum>(A)</enum><text>section 18003 of the CARES Act (<external-xref legal-doc="usc" parsable-cite="usc/20/3401">20 U.S.C. 3401</external-xref> note; <external-xref legal-doc="public-law" parsable-cite="pl/116/136">Public Law 116–136</external-xref>);</text></subparagraph><subparagraph id="HBCB16ECCCB764E7A9FD136DBF851E1F2"><enum>(B)</enum><text>section 313 of division M of the Consolidated Appropriations Act, 2021 (<external-xref legal-doc="public-law" parsable-cite="pl/116/260">Public Law 116–260</external-xref>; 134 Stat. 1929); or</text></subparagraph><subparagraph id="HB280DA677FFD4D7FA5FF67CED670F20A"><enum>(C)</enum><text>section 2001 of the American Rescue Plan Act of 2021 (<external-xref legal-doc="public-law" parsable-cite="pl/117/2">Public Law 117–2</external-xref>; 135 Stat. 19).</text></subparagraph></paragraph><paragraph id="HC2FFE6A1EE2742C1AEB31F0CFFBE4D0D"><enum>(2)</enum><header>Fentanyl awareness class or material</header><text>The term <term>fentanyl awareness class or material</term> means any program, class, or educational material designed to teach—</text><subparagraph id="HDBDEA8CBE01B4D5A9AF91D03EABB1933"><enum>(A)</enum><text display-inline="yes-display-inline">the dangers of using drugs which may be contaminated with fentanyl;</text></subparagraph><subparagraph id="H89D464A889BE4C58ABB7FC828BB02589"><enum>(B)</enum><text>the prevention of drug abuse, including through safe disposal of prescription medications and other safety precautions; and</text></subparagraph><subparagraph id="H9C98F2320DA64BAA82F1E22C7DB7D057"><enum>(C)</enum><text>the detection of early warning signs of addiction in school-aged children and youth.</text></subparagraph></paragraph><paragraph id="H2D611A6FFA514F359B408152C26C5734"><enum>(3)</enum><header>Opioid antagonist</header><text display-inline="yes-display-inline">The term <term>opioid antagonist</term> means a medication approved by the Food and Drug Administration for the purpose of rapidly reversing an opioid overdose.</text></paragraph></subsection></section></legis-body></bill> 

